Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Foshan Haitian Flavouring & Food (603288 CH)
Watchlist
196
Analysis
Consumer Staples
•
China
Foshan Haitian Flavouring & Food Company Ltd. manufactures food seasonings. The Company develops, produces, and distributes condiments including soy sauce, oyster sauce, vinegar, flavoring sauce, chicken stock, monosodium glutamate, and oil.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Foshan Haitian Flavouring and Food
•
26 May 2025 08:55
Pre-IPO Foshan Haitian Flavouring & Food Company (PHIP Updates) - Some Points Worth the Attention
Haitian faces dual challenges of "cost increase + structural transformation".Despite strong sentiment on AH listing, after all the prosperity,...
Xinyao (Criss) Wang
Follow
645 Views
Share
bullish
•
Contemporary Amperex Technology
•
26 May 2025 08:08
ECM Weekly (26 May 2025) - CATL, Hengrui, Eastroc, Haitian, Schloss, Aegis, Hyundai Marine, Pony
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
Sumeet Singh
Follow
596 Views
Share
bullish
•
Jiangsu Hengrui Pharmaceuticals
•
23 May 2025 07:07
Jiangsu Hengrui Pharma A/H Trading - Strong Demand for Quality Asset, but Is Pricey
Jiangsu Hengrui Pharmaceuticals (1276 HK) (JHP, 600276 CH ), a China-based pharmaceutical company, raised around US$1.5bn in its H-share listing....
Sumeet Singh
Follow
481 Views
Share
bullish
•
Contemporary Amperex Technology (CATL)
•
20 May 2025 07:07
CATL A/H Trading - Strong Demand, Upsized, Included in Short-Sell List
Contemporary Amperex Technology (300750 CH), one of the world’s largest battery solutions providers, raised around US$5.2bn in its H-share listing....
Sumeet Singh
Follow
926 Views
Share
bullish
•
Jiangsu Hengrui Medicine
•
15 May 2025 12:17
Jiangsu Hengrui Pharma A/H Listing - Low-End Is Probably Close to Fair Value
Jiangsu Hengrui Medicine (600276 CH), a China-based pharmaceutical company, aims to raise around US$1.3bn in its H-share listing. In this note, we...
Sumeet Singh
Follow
754 Views
Share
First
Previous
26
27
28
29
30
31
32
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x